Litigation Details for Azurity Pharmaceuticals, Inc. v. CoreRx, Inc. (M.D. Fla. 2021)
✉ Email this page to a colleague
Azurity Pharmaceuticals, Inc. v. CoreRx, Inc. (M.D. Fla. 2021)
| Docket | ⤷ Subscribe | Date Filed | 2021-10-26 |
| Court | District Court, M.D. Florida | Date Terminated | 2021-11-30 |
| Cause | Assigned To | Virginia Maria Hernandez Covington | |
| Jury Demand | Referred To | Sean P. Flynn | |
| Patents | 10,039,745; 10,154,987; 11,141,405; 6,028,222; 6,977,257; 8,568,747; 8,778,366; 9,463,183; 9,616,096; 9,669,008; 9,808,442; 9,855,214; 9,968,553 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Azurity Pharmaceuticals, Inc. v. CoreRx, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Details for Azurity Pharmaceuticals, Inc. v. CoreRx, Inc. (M.D. Fla. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-10-26 | 1 | Exhibit A | 6/2012 Nov. 2, 2017, now Pat. No. 10,039,745, which is a WO WO-2014055667 …Reference-based pricing of prescription drugs: 10,039,745 B2 8/2018 Mosher … O U.S. Pat. No. 10,039,745, issued Aug. 7, 2018), which is a …) United States Patent (10) Patent No.: US …preservative that is 65 All publications, patents, and patent applications men- sodium benzoate; and ( | External link to document |
| 2021-12-10 | 21 | Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would be motivated to combine…Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would be motivated to combine…for patent infringement of United States Patent Nos. 11,040,023 (the “’023 patent”) and…“’405 patent”) (collectively the “Patents-in-Suit”) and damages under the patent laws …infringement of U.S. Patent Nos. 11,040,023 (the “’023 patent”) and 11,141,405 the “’405 patent”) under Title | External link to document | |
| 2021-10-27 | 5 | Exhibit A | 6/2012 Nov. 2, 2017, now Pat. No. 10,039,745, which is a WO WO-2014055667 …Reference-based pricing of prescription drugs: 10,039,745 B2 8/2018 Mosher … O U.S. Pat. No. 10,039,745, issued Aug. 7, 2018), which is a …) United States Patent (10) Patent No.: US …preservative that is 65 All publications, patents, and patent applications men- sodium benzoate; and ( | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
